Pacer Advisors’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-743,904
Closed -$1.46M 2586
2026
Q1
$1.46M Sell
743,904
-65,020
-8% -$153K ﹤0.01% 1071
2025
Q4
$2.19M Sell
808,924
-62,596
-7% -$205K 0.01% 1033
2025
Q3
$3.69M Buy
+871,520
New +$3.83M 0.01% 804

Other funds holding GDRX

Pacer Advisors's GDRX Position: Q2 2026 in Review

Pacer Advisors sold out of GoodRx Holdings (GDRX) in Q2 2026, closing a stake of 743,904 shares — an estimated $1.46M sold.

Pacer Advisors first reported a position in GDRX in Q3 2025 and held it in 3 quarters. The position peaked at $3.69M in Q3 2025. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Pacer Advisors reported no remaining GoodRx Holdings position as of Q2 2026 after selling out during the quarter.
  • Pacer Advisors sold 743,904 GoodRx Holdings shares in Q2 2026, an estimated $1.46M.
  • Pacer Advisors first reported a position in GoodRx Holdings in Q3 2025 and held it in 3 quarters.
  • Pacer Advisors's GoodRx Holdings position peaked at $3.69M in Q3 2025.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.